GN in Ten

GN in Ten

A bite-size podcast brought to you by the International Society of Glomerular Disease. Nephrologists and glomerular disease experts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) take a lighthearted look at the latest research, discuss clinical practice, and interview leaders in glomerular medicine — all in a short enough time to listen on your coffee break.
00:00
00:00

Ringkasan episode

In this "Board Review Bonus" (BRB) episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain break down the essential "must-knows" for Secondary Focal Segmental Glomerulosclerosis (FSGS). Geared toward board preparation and clinical practice, this bite-sized session covers everything from distinguishing secondary lesions from primary disease to navigating the modern cardiorenal toolkit. Key Discussion Points Primary vs. Secondary Differentiation: Primary FSGS typically presents with full-blown nephrotic syndrome (heavy proteinuria, hypoalbuminemia, edema) and diffuse foot process effacement (>80%). Secondary FSGS usually manifests with indolent nephrotic-range proteinuria, normal serum albumin, and focal or mild foot process effacement. Decoding Biopsy Variants & Pathology: While Columbia classification variants (perihilar, tip, cellular, collapsing, NOS) are not strictly diagnostic on their own, specific patterns offer critical clues: Perihilar & Glomerulomegaly: Point toward maladaptive, high-flow…

Episode

21-

BRB 8: Secondary FSGS

In this "Board Review Bonus" (BRB) episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain break down the essential "must-knows" for Secondary Focal Segmental Glomerulosclerosis (FSGS). Geared toward board preparation and clinical practice, this bite-sized session covers everything from distinguishing secondary lesions from primary disease to navigating the modern cardiorenal toolkit. Key Discussion Points Primary vs. Secondary Differentiation: Primary FSGS typically presents with full-blown nephrotic syndrome (heavy proteinuria, hypoalbuminemia, edema) and diffuse foot process effacement (>80%). Secondary FSGS usually manifests with indolent nephrotic-range proteinuria, normal serum albumin, and focal or mild foot process effacement. Decoding Biopsy Variants & Pathology: While Columbia classification variants (perihilar, tip, cellular, collapsing, NOS) are not strictly diagnostic on their own, specific patterns offer critical clues: Perihilar & Glomerulomegaly: Point toward maladaptive, high-flow…

27 Okt 2026
20-

Board Review Bonus 7: Membranous Nephropathy

Board Review Bonus 7: Membranous Nephropathy In this "Board Review Bonus" (BRB) episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain deliver a high-yield clinical overview of membranous nephropathy (MN)—a classic, board-favorite cause of nephrotic syndrome. Utilizing a real-world case of a 50-year-old male presenting with heavy proteinuria and severe hypoalbuminemia, they walk through diagnostic dilemmas, pathological clues, and the modern therapeutic landscape. Whether you are studying for the boards or looking to "class-switch" your clinical knowledge from IgG1 to IgG4, this bite-sized episode is packed with essential clinical pearls. Key Topics Covered: Epidemiology & Biopsy Basics: Identifying MN as one of the most common causes of adult nephrotic syndrome. The hosts break down classic pathology features: diffuse GBM thickening on light microscopy, "spikes" on silver stain, granular IgG and C3 immunofluorescence, and subepithelial dense deposits on EM. The Antigen Revolution: A review of how the 2009…

17 Jul 2026
19-

Board Review Bonus 6: Alport Syndrome

Board Review Bonus 6: Alport Syndrome In this "Board Review Bonus" (BRB) episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—also known as Alport syndrome—a complex genetic condition with critical renal and extrarenal implications. From a sneaky real-world case of an 18-year-old female presenting with isolated microscopic hematuria to classic textbook syndromic features , our hosts break down the essential knowledge required for both board preparation and clinical practice. The discussion moves beyond the classic X-linked male phenotype to explore autosomal varieties and why thin basement membrane disease (TBMD) is increasingly viewed as part of the Alport spectrum rather than a purely benign entity. Dr. Jain and Dr. Jhaveri emphasize critical management strategies, highlighting why an accurate diagnosis is vital to protect patients from receiving unnecessary and ineffective immunosuppressive therapies. Key Topics Covered: The Hematuria…

16 Jun 2026
18-

Board Review Bonus 5: Renal Amyloidosis

Episode 5: Board Review Bonus: Renal Amyloidosis In this "Board Review Bonus" (BRB) episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain provide a comprehensive clinical overview of amyloidosis—a complex and often enigmatic disease with significant renal implications. From the initial "mushy, smudgy" appearance on light microscopy to the precise measurements of electron microscopy, our hosts break down the essential knowledge required for both board preparation and clinical practice. The discussion moves beyond the common AL and AA variants to explore rare types like LECT2 and the hereditary forms. Dr. Jain and Dr. Jhaveri emphasize that "the tissue is the issue," highlighting the diagnostic necessity of biopsying the affected organ and the critical role of mass spectrometry in directing therapy. Key Topics Covered: Classification of Amyloidosis: A detailed look at AL, AA, LECT2, and the hereditary variants including ATTR, fibrinogen A alpha-chain, and Apolipoprotein. The Diagnostic Workup: Understanding the…

29 Apr 2026
17-

Episode 11: Nephmadness Special! Matt Sparks and Aarushi Varshney on C3G

In this episode, hosts Dr. Kenar Jhaveri and Dr. Koyal Jain are joined by Dr. Matt Sparks (co-creator of NephMadness) and Dr. Aarushi Varshney to discuss the evolving landscape of C3 Glomerulopathy (C3G). The conversation highlights the shift from traditional electron microscopy-based classifications to modern immunofluorescence-based diagnosis, as well as the groundbreaking arrival of two new FDA-approved targeted therapies. The NephMadness Matchup This episode focuses on the C3G bracket pitting two critical aspects of C3G against each other: Team Diagnosis: Focusing on the challenges of distinguishing C3G from infection-related GN or monoclonal gammopathy. Team Treatment: Highlighting the new era of factor B and C3 inhibitors that are revolutionizing patient outcomes. Key Takeaways 1. Challenges in Diagnosis The "Two Orders of Magnitude" Rule: Modern diagnosis is based on immunofluorescence (IF) showing C3 deposition that is at least two orders of magnitude greater than any other immunoglobulin. C3G vs.…

11 Mar 2026